Maria Salvadó Figueras Maria Salvado has worked in the Vall d’Hebron Research Institute and the Neurology Department at Hospital Universitari Vall d’Hebron in Barcelona since 2012, where his clinical work focuses on treatment of neuromuscular disorders. Instituciones de las que forman parte Investigador postdoctoral Sistema Nervioso Periférico Vall Hebron Institut de Recerca Neurología Hospital General Email Maria Salvadó Figueras Email Instituciones de las que forman parte Investigador postdoctoral Sistema Nervioso Periférico Vall Hebron Institut de Recerca Neurología Hospital General Maria Salvado has worked in the Vall d’Hebron Research Institute and the Neurology Department at Hospital Universitari Vall d’Hebron in Barcelona since 2012, where his clinical work focuses on treatment of neuromuscular disorders.
She works as a neurologist at the Neuromuscular and Rare Diseases Unit of Vall d'Hebron Hospital and as a researcher in the Peripheral Nervous System Disease Research Laboratory (VHIR), currently led by Dr. R. Juntas-Morales. The main lines of this research group are based on the identification of new biomarkers and genetic determinants in familial and sporadic forms of amyotrophic lateral sclerosis (ALS), autoimmune myasthenia gravis (MG), and genetic-based myopathies and neuropathies. She is also one of the professionals in the European Network for Neuromuscular and Rare Diseases (EURO-NMD ERN) and the European Network for rare neurological diseases (ERN-RND). Hospital Vall d’Hebron is member of these ERNs. She is co-author of more than 20 peer-reviewed articles and in February 2020, she obtained her PhD title from the Autonomous University of Barcelona for her thesis entitled "Study of genetic factors that influence the familial and sporadic forms of myasthenia gravis autoimmune ”(Teseo, TDX). In 2013, she was awarded the Scientific Poster Award at the International Symposium for ALS (MNDA). She is a co-investigator for several grants, research projects and clinical trials, including FIS (Fondo de Investigación Sanitarias) and MINECO (Ministerio de Economía y Competitividad) grants. These grants are for studies of rare neurological diseases such as ALS, myasthenia gravis, familial amyloid polyneuropathy (Corino-Andrade disease), mitochondrial diseases and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Proyectos Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients IP: Raul Juntas Morales Colaboradores: Margarita Gratacós Viñola, Maria Salvadó Figueras, Nuria Raguer Sanz, David Ovelleiro Fraile, Consuelo Garcia Carmona, José Manuel Vidal Taboada, Javier Joaquín Sotoca Fernández, Arnau Llauradó Gayete, Daniel Sánchez-Tejerin San José Entidad financiadora: Fundación Francisco Luzón Financiación: 139000 Referencia: FCO.LUZON/PROJECTES/2024/JUNTAS Duración: 12/12/2024 - 11/12/2027 Desarrollo e implementación de un nuevo panel de biomarcadores clínicos y moleculares para pronosticar la progresión y la supervivencia en pacientes con ELA IP: Raul Juntas Morales Colaboradores: Margarita Gratacós Viñola, Maria Salvadó Figueras, Nuria Raguer Sanz, David Ovelleiro Fraile, José Manuel Vidal Taboada, Javier Joaquín Sotoca Fernández, Arnau Llauradó Gayete, Daniel Sánchez-Tejerin San José Entidad financiadora: Instituto de Salud Carlos III Financiación: 190000 Referencia: PI23/00850 Duración: 01/01/2024 - 31/12/2026 GRE: Sistema Nerviòs Perifèric IP: Raul Juntas Morales Colaboradores: Anna Belen Canovas Segura, Maria Salvadó Figueras, Consuelo Garcia Carmona, José Manuel Vidal Taboada, Javier Joaquín Sotoca Fernández, Arnau Llauradó Gayete, Daniel Sánchez-Tejerin San José Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca Financiación: 0.01 Referencia: 2021 SGR 01121 Duración: 01/01/2022 - 30/06/2025 Genotipado de alta resolución de los genes HLA y análisis de su expresión en el SNC en Esclerosis Lateral Amiotrófica como factor de riesgo: Investigando la hipótesis neuroinflamatoria IP: José Manuel Vidal Taboada Colaboradores: Maria Jose Herrero Mata, Maria Salvadó Figueras, Josep Gamez Carbonell, Consuelo Garcia Carmona, Arnau Llauradó Gayete Entidad financiadora: Instituto de Salud Carlos III Financiación: 117370 Referencia: PI19/00593 Duración: 01/01/2020 - 30/06/2024 Paginación Página actual 1 Página 2 Siguiente página › Última página »
